Recombinant DNA technology and chimeric protein expression to enhance the production of therapeutic peptides in microbial systems

Gianluca Bertetti, Senior R&D Researcher of Olon had a speech last 16th of May during TIDEs USA 2024, the event dedicated to Oligonucleotide & Peptide Therapeutics.

Recombinant DNA technology, in recent era, has demonstrated unique impacts in bringing advancement in human life. By virtue of this technology, crucial proteins and peptides required for health problems and dietary purposes can be produced safely and sufficiently at a reasonable cost.

Olon is developing a universal microbial platform for the production of peptides to be used directly as therapeutics or as substrate for semi-synthetic drugs assembly.

Here you can find his speech: OLON TIDES_2024